(Q60197408)

English

Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)

scientific article published on 03 August 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Maria Ana Martinez-Castellanos

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Lihteh Wu

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hugo Quiroz-Mercado

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

J Fernando Arevalo

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

María H Berrocal

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Michel E Farah

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Mauricio Maia

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

José A Roca

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Francisco J Rodriguez

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Pan American Collaborative Retina Group (PACORES)

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

3 August 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Graefe's Archive for Clinical and Experimental Ophthalmology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

246

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

81-87

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

https://scigraph.springernature.com/pub.10.1007/s00417-007-0660-z

0 references

Effects of bevacizumab on retinal function in isolated vertebrate retina

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrophysiologic findings after intravitreal bevacizumab (Avastin) treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenesis and ophthalmic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does intravitreal injection of bevacizumab have an effect on the blood-aqueus barrier function?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of vascular endothelial growth factor in ocular health and disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pegaptanib for neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genentech discloses safety concerns over Avastin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risks of intravitreous injection: a comprehensive review

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGF-initiated blood-retinal barrier breakdown in early diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitors of ocular neovascularization: promises and potential problems.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab: Phase III clinical trial results

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolving guidelines for intravitreous injections

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Testing intravitreal toxicity of bevacizumab (Avastin).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenic growth factors and hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) treatment is safe in terms of intraocular and blood pressure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17674014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00417-007-0660-Z

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17674014%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q60197408&oldid=1783588549"